ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1571693
This article is part of the Research TopicObesity and Metabolism in Endocrine-Related CancersView all 4 articles
Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on future endometrial cancer risk and the mediating role of body mass index: a cross-sectional study
Provisionally accepted
- Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The triglyceride-glucose (TyG) index, a promising biomarker for insulin resistance, is linked to the risk of various metabolic-related cancers. However, to date, data on the association of TyG index with different subtypes of endometrial cancers and the potential mediating role of clinical factors remain limited.Methodology: Data was collected from the Beijing Obstetrics and Gynecology Hospital, Capital Medical University spanning from 2014 to 2024. Female participants with complete data on the TyG index were included in the analysis. Multivariate logistic regression analyses were used to assess the association of TyG index with endometrial cancer risk, adjusted by series of confounders. Mediation effects were evaluated using Valeri and VanderWeele's method.Results: A total of 1,194 eligible participants were enrolled, with 597 (50%) women diagnosed with endometrial cancer. The fully adjusted multivariate logistic regression model revealed a significant association between the TyG index and the risk of endometrial cancer (odds ratio [OR]Tertile 3 versus Tertile 1: 1.93, 95% confidence interval [CI]: 1.37-2.73; P for trend=0.028). Notably, BMI exhibited significant mediation effects on this association, even after adjusted by potential confounders (P for trend<0.001). The proportion of the effect mediated by BMI was 25% in the crude analysis (95% CI: 0.15, 0.37; P<0.001) and increased to 41% in the adjusted analysis (95% CI: 0.24, 0.76; P<0.001).However, no correlation was found between TyG index and the clinical characteristics of endometrial cancer (P>0.05). Moreover, BMI is associated with the risk of different endometrial cancers.This cross-sectional study demonstrated that a higher TyG index, representing higher level of insulin resistance, was associated with a higher risk of endometrial cancer. Importantly, we found that BMI acted as a significant mediator in this relationship. Prospective studies are needed to further validate these findings.
Keywords: endometrial cancer1, metabolic syndrome2, triglyceride-glucose index3, insulin resistance4, Body mass index5, mediation effect6
Received: 05 Feb 2025; Accepted: 20 May 2025.
Copyright: © 2025 Wang, Liu, Kong, Xu, Geng and Miao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yixiao Wang, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Jinwei Miao, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.